Patent: 8,771,699
Summary for Patent: 8,771,699
| Title: | Magnetic transducers |
| Abstract: | Embodiments herein relate to the production of biocompatible magnetic nanoparticles with a high SAR-value which produce a large amount of heat when exposed to an alternating magnetic field. The produced heat can be used among others for therapeutic purposes, in particular for combating cancer. |
| Inventor(s): | Norbert Waldoefner, Kerstin Stief |
| Assignee: | Magforce AG |
| Application Number: | US12/738,970 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,771,699
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | SYLVANT | siltuximab | For Injection | 125496 | April 23, 2014 | 8,771,699 | 2029-01-09 |
| Eusa Pharma (uk) Limited | SYLVANT | siltuximab | For Injection | 125496 | April 23, 2014 | 8,771,699 | 2029-01-09 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,771,699
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2009203851 | ⤷ Start Trial |
| Brazil | PI0905620 | ⤷ Start Trial |
| Canada | 2707523 | ⤷ Start Trial |
| China | 101888976 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
